{
  "main_header": {
    "sid": 597145,
    "name": "Cipla",
    "stock_name": "Cipla",
    "full_name": "Cipla Ltd.",
    "name_url": "stocks-analysis/cipla",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,518.00",
    "chg": -3.2,
    "chgp": "-0.21%",
    "dir": -1,
    "prev_price": "1,521.20",
    "mcapval": "122,619.67 Cr",
    "mcap": "Large Cap",
    "scripcode": 500087,
    "symbol": "CIPLA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE059A01026",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "28.31 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/cipla-597145-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Cipla Ltd: Navigating Market Dynamics as a Nifty 50 Pharmaceutical Leader",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ciplas-market-performance-and-nifty-50-membership-a-detailed-analysis-3745794",
        "imagepath": "",
        "date": "2025-12-04 09:20:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Index Membership and Market Significance</strong></p>\n                <p>Cipla Ltd’s inclusion in the Nifty 50 index places it among India’s most influential and widely tracked stocks. This membership not only reflects the company’s substantial market capitalisation, currently valued at approximately ₹1,21,570 crores, but also highlights its importance in shaping sectoral and broader market trends. As a large-cap pharmaceutical stock, Cipla serves as a bellwether for investor sentiment within the Pharmaceuticals & Biotechnology sector, which remains a critical component of the Indian equity market.</p>\n                <p>The company’s price-to-earnings (P/E) ratio stands at 22.39, notably below the sector average of 33.90, indicating a valuation that may be perceived as more c..."
      },
      {
        "title": "Cipla Ltd: Navigating Market Dynamics as a Key Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ciplas-nifty-50-membership-reinforces-its-market-standing-amid-mixed-performance-3743251",
        "imagepath": "",
        "date": "2025-12-03 09:20:42",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Cipla Ltd among the most influential and widely tracked companies on the National Stock Exchange of India. This membership not only reflects the company's sizeable market capitalisation but also its liquidity and sectoral representation. Inclusion in the index often attracts institutional investors and passive funds that replicate the benchmark, thereby impacting the stock's demand and trading volumes.</p>\n                <p>For Cipla, this status means that its stock movements can have a material effect on the overall index performance, especially given the Pharmaceuticals & Biotechnology sector's growing prominence in the Indian economy. The company's presence in the i..."
      },
      {
        "title": "Is Cipla technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-cipla-technically-bullish-or-bearish-3740347",
        "imagepath": "",
        "date": "2025-12-02 08:55:37",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Current Technical Landscape</strong></p>\n<p>The latest technical trend for Cipla has transitioned from mildly bullish to a sideways stance as of 1 December 2025. This shift indicates a period of consolidation where neither buyers nor sellers dominate decisively. The stock’s current price stands at ₹1,524.40, slightly below the previous close of ₹1,530.95, reflecting a modest pullback within a relatively narrow intraday range between ₹1,518.00 and ₹1,536.20.</p>\n<p>Over the past 52 weeks, Cipla has traded between ₹1,310.05 and ₹1,672.20, highlighting a significant price range that investors should consider when evaluating volatility and potential support and resistance levels.</p>\n<p><strong>Momentum Indicators Paint a Mixed Picture</strong></p>\n<p>Examining key momentum indicators reveals a ..."
      },
      {
        "title": "Cipla Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/cipla-shares-shift-to-sideways-momentum-amid-mixed-technical-signals-3740110",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/Cipla_technicaldot_3740110.png",
        "date": "2025-12-02 08:06:47",
        "description": "Cipla, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments reflect a transition from a mildly bullish trend to a sideways movement. This development is underscored by a blend of signals from prominent technical indicators including MACD, RSI, Bollinger Bands, and moving averages, painting a complex picture for investors analysing the stock’s near-term trajectory."
      },
      {
        "title": "Cipla Ltd: Navigating Nifty 50 Membership and Institutional Holding Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ciplas-nifty-50-membership-highlights-institutional-shifts-and-market-performance-3737624",
        "imagepath": "",
        "date": "2025-12-01 09:20:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Cipla’s inclusion in the Nifty 50 index underscores its stature as one of India’s leading large-cap pharmaceutical companies. With a market capitalisation of approximately ₹1,23,766.71 crores, Cipla ranks among the top-tier stocks that influence the overall movement of the index. The Nifty 50, being a barometer of the Indian equity market, reflects the economic health and sectoral trends, making Cipla’s performance a focal point for investors tracking the pharmaceutical sector.</p>\n                <p>As a benchmark constituent, Cipla’s stock price movements often mirror broader sectoral shifts and investor sentiment. The stock’s trading behaviour, including its recent five-day consecutive gains amounting to a ..."
      },
      {
        "title": "Cipla Ltd: Navigating Nifty 50 Membership and Institutional Holding Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ciplas-nifty-50-membership-underlines-its-strategic-market-position-amid-mixed-performance-3734841",
        "imagepath": "",
        "date": "2025-11-28 09:20:52",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership for Cipla Ltd</strong></p>\n                <p>Being a constituent of the Nifty 50 index places Cipla Ltd among the top-tier companies in India’s equity market, underscoring its large-cap status with a market capitalisation of approximately ₹1,23,250 crores. This membership not only enhances the stock’s visibility among domestic and international investors but also ensures inclusion in numerous index-tracking funds and ETFs, which can influence liquidity and demand dynamics.</p>\n                <p>The pharmaceutical sector, represented robustly within the Nifty 50, has witnessed mixed results in recent quarters. Out of 32 companies in the Pharmaceuticals & Drugs sector that declared results, 11 reported positive outcomes, 12 remained flat, an..."
      },
      {
        "title": "Cipla Ltd: Navigating Nifty 50 Membership and Market Dynamics in Pharmaceuticals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ciplas-market-position-and-institutional-dynamics-amid-nifty-50-membership-3732831",
        "imagepath": "",
        "date": "2025-11-27 09:20:50",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Significance of Nifty 50 Membership</strong></p>\n                <p>Being part of the Nifty 50 index places Cipla Ltd among the elite group of companies that represent the broader Indian equity market’s health and direction. This membership not only enhances the stock’s visibility but also attracts significant institutional interest, including mutual funds, insurance companies, and foreign portfolio investors who often align their portfolios with benchmark indices. The inclusion in Nifty 50 implies that Cipla’s stock movements can have a material impact on the index’s overall trajectory, making it a key barometer for sectoral and market-wide trends.</p>\n\n                <p><strong>Market Capitalisation and Valuation Metrics</strong></p>\n                <p>Cipla’s market capita..."
      },
      {
        "title": "Cipla's Evaluation Metrics Revised Amid Mixed Financial and Market Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/cipla-downgraded-from-buy-to-hold-by-marketsmojo-on-30-oct-2025-3730875",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/Cipla_mojoScore_3730875.png",
        "date": "2025-11-26 09:46:39",
        "description": "Cipla, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently undergone a revision in its evaluation metrics reflecting a nuanced market assessment. This shift comes amid a backdrop of steady operational fundamentals and a complex performance trajectory relative to its sector peers and broader market indices."
      },
      {
        "title": "Cipla Ltd: Navigating Market Dynamics as a Key Nifty 50 Constituent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ciplas-nifty-50-membership-highlights-institutional-shifts-amid-sector-challenges-3730540",
        "imagepath": "",
        "date": "2025-11-26 09:20:55",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <p><strong>Index Membership and Market Capitalisation</strong></p>\n                <p>Cipla Ltd holds a substantial market capitalisation of approximately ₹1,21,973.45 crores, categorising it firmly as a large-cap stock. Its inclusion in the Nifty 50 index not only reflects its size but also its influence on the benchmark’s overall performance. As one of the leading pharmaceutical companies in India, Cipla’s stock movements contribute materially to the index’s daily fluctuations, making it a focal point for institutional investors and index funds tracking the Nifty 50.</p>\n                <p>Being part of the Nifty 50 also means Cipla is subject to heightened scrutiny and liquidity demands. This status often results in increased trading volumes and greater analyst coverage, factors that ..."
      }
    ],
    "total": 864,
    "sid": "597145",
    "stock_news_url": "https://www.marketsmojo.com/news/cipla-597145"
  },
  "announcements": [
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "01-Dec-2025",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Life Insurance Corporation of India",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "06-Nov-2025",
      "details": "Newspaper publication regarding special window for re- lodgement of transfer requests of physical shares",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
      "datetime": "03-Nov-2025",
      "details": "Acquisition of securities in Inzpera Healthsciences Limited",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has declared <strong>650%</strong> dividend, ex-date: 27 Jun 25",
          "dt": "2025-06-27",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Cipla Ltd. has announced <strong>3:2</strong> bonus issue, ex-date: 24 Apr 06",
          "dt": "2006-04-24",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Cipla Ltd: Navigating Market Dynamics as a Nifty 50 Pharmaceutical Leader

2025-12-04 09:20:50

Index Membership and Market Significance

Cipla Ltd’s inclusion in the Nifty 50 index places it among India’s most influential and widely tracked stocks. This membership not only reflects the company’s substantial market capitalisation, currently valued at approximately ₹1,21,570 crores, but also highlights its importance in shaping sectoral and broader market trends. As a large-cap pharmaceutical stock, Cipla serves as a bellwether for investor sentiment within the Pharmaceuticals & Biotechnology sector, which remains a critical component of the Indian equity market.

The company’s price-to-earnings (P/E) ratio stands at 22.39, notably below the sector average of 33.90, indicating a valuation that may be perceived as more c...

Read More

Cipla Ltd: Navigating Market Dynamics as a Key Nifty 50 Constituent

2025-12-03 09:20:42

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Cipla Ltd among the most influential and widely tracked companies on the National Stock Exchange of India. This membership not only reflects the company's sizeable market capitalisation but also its liquidity and sectoral representation. Inclusion in the index often attracts institutional investors and passive funds that replicate the benchmark, thereby impacting the stock's demand and trading volumes.

For Cipla, this status means that its stock movements can have a material effect on the overall index performance, especially given the Pharmaceuticals & Biotechnology sector's growing prominence in the Indian economy. The company's presence in the i...

Read More

Is Cipla technically bullish or bearish?

2025-12-02 08:55:37

Current Technical Landscape

The latest technical trend for Cipla has transitioned from mildly bullish to a sideways stance as of 1 December 2025. This shift indicates a period of consolidation where neither buyers nor sellers dominate decisively. The stock’s current price stands at ₹1,524.40, slightly below the previous close of ₹1,530.95, reflecting a modest pullback within a relatively narrow intraday range between ₹1,518.00 and ₹1,536.20.

Over the past 52 weeks, Cipla has traded between ₹1,310.05 and ₹1,672.20, highlighting a significant price range that investors should consider when evaluating volatility and potential support and resistance levels.

Momentum Indicators Paint a Mixed Picture

Examining key momentum indicators reveals a ...

Read More

Cipla Technical Momentum Shifts Amid Mixed Indicator Signals

2025-12-02 08:06:47

Cipla, a key player in the Pharmaceuticals & Biotechnology sector, is exhibiting a nuanced shift in its technical momentum as recent evaluation adjustments reflect a transition from a mildly bullish trend to a sideways movement. This development is underscored by a blend of signals from prominent technical indicators including MACD, RSI, Bollinger Bands, and moving averages, painting a complex picture for investors analysing the stock’s near-term trajectory.

Read More

Cipla Ltd: Navigating Nifty 50 Membership and Institutional Holding Dynamics

2025-12-01 09:20:58

Significance of Nifty 50 Membership

Cipla’s inclusion in the Nifty 50 index underscores its stature as one of India’s leading large-cap pharmaceutical companies. With a market capitalisation of approximately ₹1,23,766.71 crores, Cipla ranks among the top-tier stocks that influence the overall movement of the index. The Nifty 50, being a barometer of the Indian equity market, reflects the economic health and sectoral trends, making Cipla’s performance a focal point for investors tracking the pharmaceutical sector.

As a benchmark constituent, Cipla’s stock price movements often mirror broader sectoral shifts and investor sentiment. The stock’s trading behaviour, including its recent five-day consecutive gains amounting to a ...

Read More

Cipla Ltd: Navigating Nifty 50 Membership and Institutional Holding Dynamics

2025-11-28 09:20:52

Significance of Nifty 50 Membership for Cipla Ltd

Being a constituent of the Nifty 50 index places Cipla Ltd among the top-tier companies in India’s equity market, underscoring its large-cap status with a market capitalisation of approximately ₹1,23,250 crores. This membership not only enhances the stock’s visibility among domestic and international investors but also ensures inclusion in numerous index-tracking funds and ETFs, which can influence liquidity and demand dynamics.

The pharmaceutical sector, represented robustly within the Nifty 50, has witnessed mixed results in recent quarters. Out of 32 companies in the Pharmaceuticals & Drugs sector that declared results, 11 reported positive outcomes, 12 remained flat, an...

Read More

Cipla Ltd: Navigating Nifty 50 Membership and Market Dynamics in Pharmaceuticals

2025-11-27 09:20:50

Significance of Nifty 50 Membership

Being part of the Nifty 50 index places Cipla Ltd among the elite group of companies that represent the broader Indian equity market’s health and direction. This membership not only enhances the stock’s visibility but also attracts significant institutional interest, including mutual funds, insurance companies, and foreign portfolio investors who often align their portfolios with benchmark indices. The inclusion in Nifty 50 implies that Cipla’s stock movements can have a material impact on the index’s overall trajectory, making it a key barometer for sectoral and market-wide trends.

Market Capitalisation and Valuation Metrics

Cipla’s market capita...

Read More

Cipla's Evaluation Metrics Revised Amid Mixed Financial and Market Signals

2025-11-26 09:46:39

Cipla, a prominent player in the Pharmaceuticals & Biotechnology sector, has recently undergone a revision in its evaluation metrics reflecting a nuanced market assessment. This shift comes amid a backdrop of steady operational fundamentals and a complex performance trajectory relative to its sector peers and broader market indices.

Read More

Cipla Ltd: Navigating Market Dynamics as a Key Nifty 50 Constituent

2025-11-26 09:20:55

Index Membership and Market Capitalisation

Cipla Ltd holds a substantial market capitalisation of approximately ₹1,21,973.45 crores, categorising it firmly as a large-cap stock. Its inclusion in the Nifty 50 index not only reflects its size but also its influence on the benchmark’s overall performance. As one of the leading pharmaceutical companies in India, Cipla’s stock movements contribute materially to the index’s daily fluctuations, making it a focal point for institutional investors and index funds tracking the Nifty 50.

Being part of the Nifty 50 also means Cipla is subject to heightened scrutiny and liquidity demands. This status often results in increased trading volumes and greater analyst coverage, factors that ...

Read More

View All News